Kuo-Hsing Lee
Affiliations: | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Pharmaceutical Chemistry, OncologyGoogle:
"Kuo-Hsing Lee"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wan Q, Jin X, Guo Y, et al. (2020) New Seco-DSP derivatives as potent chemosensitizers. European Journal of Medicinal Chemistry. 204: 112555 |
| Qian J, Xu Z, Meng C, et al. (2020) Design and synthesis of benzylidenecyclohexenones as TrxR inhibitors displaying high anticancer activity and inducing ROS, apoptosis, and autophagy. European Journal of Medicinal Chemistry. 204: 112610 |
| Shang XF, Yang CJ, Morris-Natschke SL, et al. (2020) Biologically active isoquinoline alkaloids covering 2014-2018. Medicinal Research Reviews |
| Huang XL, Chen JL, Li XL, et al. (2020) Synthesis and anticancer activities of biotinylated derivatives of glaucocalyxin A and oridonin. Journal of Asian Natural Products Research. 1-9 |
| Yuan WH, Teng MT, Yun YF, et al. (2020) Talarolactone A, an Isocoumarin Derivative Fused with Dihydrothiophene with Selective Antimigratory Activity from the Endolichenic Fungus sp. Journal of Natural Products |
| Lee DY, Hou YC, Yang JS, et al. (2020) Synthesis, Anticancer Activity, and Preliminary Pharmacokinetic Evaluation of 4,4-Disubstituted Curcuminoid 2,2-bis(Hydroxymethyl)Propionate Derivatives. Molecules (Basel, Switzerland). 25 |
| Jiang L, Goto M, Zhu DQ, et al. (2020) Scaffold Hopping-Driven Optimization of 4-(Quinazolin-4-yl)-3,4-dihydroquinoxalin-2(1)-ones as Novel Tubulin Inhibitors. Acs Medicinal Chemistry Letters. 11: 83-89 |
| Yang CJ, Li B, Zhang ZJ, et al. (2019) Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin. European Journal of Medicinal Chemistry. 187: 111971 |
| Chen Z, Huang KY, Ling Y, et al. (2019) Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer. Journal of Natural Products |
| Aimaiti S, Saito Y, Fukuyoshi S, et al. (2019) Isolation, Structure Elucidation, and Antiproliferative Activity of Butanolides and Lignan Glycosides from the Fruit of . Molecules (Basel, Switzerland). 24 |